课题基金 / 基金详情

Role of intravascular ERO1@ in acute lung injury

Role of intravascular ERO1@ in acute lung injury
血管内ERO1@在急性肺损伤中的作用
批准号:
10469645
负责人:
Jaehyung Cho
金额:
$37.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-21 至 2024-08-31

项目摘要

项目成果

Jaehyung Cho的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Acute lung injury (ALI) is a life-threatening condition, which affects > 200,000 patients annually in the U.S. It is associated with pneumonia, sepsis, and trauma, leading to pulmonary insufficiency and eventually multisystem organ failure. Since excessive recruitment of activated neutrophils to lung microvessels is a primary cause of ALI, a better understanding of the mechanism mediating neutrophil-endothelial cell interactions will provide insight into developing an effective therapeutic for treating ALI. We previously demonstrated that intravascular protein disulfide isomerase (PDI) enhances the ligand-binding activity of neutrophil and platelet surface receptors and leads to intravascular cell-cell interactions during vascular inflammation. To elucidate how extracellular PDI activity is regulated and whether the regulatory mechanism contributes to the pathology of ALI, we have found that endoplasmic reticulum oxidoreductin 1α (ERO1α, a key oxidase of PDI in the ER) promotes neutrophil recruitment during vascular inflammation. In this proposal, we will test the hypothesis that intravascular ERO1α enhances the ligand-binding function of neutrophil adhesion receptors by modifying disulfide bonds, inducing neutrophil recruitment to sites of acute lung inflammation. In Aim 1, we will determine the mechanism by which ERO1α regulates neutrophil-endothelial cell interactions. In Aim 2, we will utilize lung live imaging techniques to investigate the pathological role of intravascular ERO1α in ALI. In Aim 3, using the blood of patients with acute respiratory distress syndrome (ARDS), we will determine the contribution of ERO1α to the disease progression and severity in patients with ARDS. These studies will employ biochemical, cell biological, genetic, and confocal intravital imaging approaches. Since little is known about extracellular thiol-modifying machinery, the proposed studies will identify an essential, yet unexplored, mechanism that promotes the pathogenesis of ALI/ARDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes
  • 批准号:
    10765748
  • 项目类别:
  • 资助金额:
    $32.35万
  • 财政年份:
    2023
  • 负责人:
    Jaehyung Cho
  • 依托单位:
ERO1 alpha in platelet activity and thrombosis
  • 批准号:
    10321687
  • 项目类别:
  • 资助金额:
    $43.72万
  • 财政年份:
    2020
  • 负责人:
    Jaehyung Cho
  • 依托单位:
Identification of an inhibitor of PDI-GPIbalpha signaling as a novel antithromboinflammatory agent
  • 批准号:
    10242945
  • 项目类别:
  • 资助金额:
    $55.13万
  • 财政年份:
    2020
  • 负责人:
    Jaehyung Cho
  • 依托单位:
Identification of an inhibitor of PDI-GPIbalpha signaling as a novel antithromboinflammatory agent
  • 批准号:
    10253656
  • 项目类别:
  • 资助金额:
    $55.13万
  • 财政年份:
    2020
  • 负责人:
    Jaehyung Cho
  • 依托单位:
海外基金